Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

79.03
+0.56000.71%
Post-market: 79.030.00000.00%19:57 EDT
Volume:270.11K
Turnover:21.38M
Market Cap:6.17B
PE:79.83
High:79.93
Open:78.28
Low:78.01
Close:78.47
52wk High:82.94
52wk Low:32.89
Shares:78.02M
Float Shares:40.19M
Volume Ratio:0.54
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9900
EPS(LYR):0.7500
ROE:14.04%
ROA:8.05%
PB:9.43
PE(LYR):105.37

Loading ...

Cardiovascular drugmaker Kiniksa's Q1 net income rises

Reuters
·
Apr 28

Stock Track | Kiniksa Pharmaceuticals Soars 8.67% in Pre-Market on Raised Revenue Guidance and Strong Q1 Results

Stock Track
·
Apr 28

Kiniksa Q1 net income rises to $22.6 million; net product revenue climbs 56% to $214.3 million

Reuters
·
Apr 28

Earnings Flash (KNSA) Kiniksa Pharmaceuticals Posts Q1 EPS $0.27

MT Newswires Live
·
Apr 28

BRIEF-Kiniksa Pharmaceuticals Q1 Product Revenue USD 214.266 Million

Reuters
·
Apr 28

Kiniksa Pharmaceuticals Q1 Pretax Profit USD 32.681 Million

THOMSON REUTERS
·
Apr 28

Kiniksa Pharmaceuticals International Plc - Raises 2026 Arcalyst Net Product Revenue Guidance to $930-$945 Mln

THOMSON REUTERS
·
Apr 28

Kiniksa Pharmaceuticals International Plc - Kpl-387 Phase 2 Data Expected 2H 2026; Phase 3 Trial to Initiate by Year-End

THOMSON REUTERS
·
Apr 28

Kiniksa Pharmaceuticals International Plc - Cash and Short-Term Investments $468.1 Mln as of March 31, 2026

THOMSON REUTERS
·
Apr 28

Kiniksa Pharmaceuticals International PLC expected to post earnings of 21 cents a share - Earnings Preview

Reuters
·
Apr 24

Kiniksa Pharmaceuticals schedules first-quarter results conference call and webcast

Reuters
·
Apr 24

Kiniksa Pharmaceuticals Is Maintained at Outperform by Wedbush

Dow Jones
·
Apr 16

Kiniksa price target raised to $58 from $53 at Wedbush

TIPRANKS
·
Apr 16

Wedbush Raises Price Target on Kiniksa Pharmaceuticals International to $58 From $53, Keeps Outperform Rating

MT Newswires Live
·
Apr 16

Wells Fargo Keeps Their Buy Rating on Kiniksa Pharmaceuticals (KNSA)

TIPRANKS
·
Apr 14

Kiniksa Chief Accounting Officer Michael R. Megna disposes of $309,831 common shares

Reuters
·
Apr 14

Kiniksa COO Ross Moat disposes 1,703 shares for $79,501.07

Reuters
·
Apr 14

Kiniksa CEO Sanj K Patel disposes 7,278 shares worth $364,673

Reuters
·
Apr 09

Kiniksa COO Ross Moat disposes of USD 152,981 in common shares

Reuters
·
Apr 09

Kiniksa director Barry Quart disposes 6,901 shares for $345,104

Reuters
·
Apr 09